XML 78 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Research and development $ 80,046 $ 83,215
General and administrative 18,006 16,008
Total operating expenses 98,052 99,223
Loss from operations (98,052) (99,223)
Other income (expense):    
Interest income 3,390 3,075
Change in fair value of the tranche rights (4,796) 0
Other income (expense), net (1,049) 2,536
Total other income (expense), net (2,455) 5,611
Net loss $ (100,507) $ (93,612)
Net loss per share, basic (in usd per share) $ (1.00) $ (2.11)
Net loss per share, diluted (in usd per share) $ (1.00) $ (2.11)
Weighted-average common shares outstanding, basic (in shares) 100,174,766 44,320,050
Weighted-average common shares outstanding, diluted (in shares) 100,174,766 44,320,050